Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CMA clears Microsoft acquisition of Inflection AI assets

(Sharecast News) - The Competition and Markets Authority (CMA) has approved Microsoft's acquisition of key personnel and intellectual property from Inflection AI, it announced on Wednesday, determining that the deal does not significantly impact competition in the artificial intelligence (AI) market. Microsoft's acquisition, announced in March, involved hiring most of Inflection AI's team, including its co-founders, Mustafa Suleyman and Karén Simonyan.

The deal also included licensing arrangements related to Inflection's intellectual property.

The CMA reviewed the transaction to assess its potential impact on competition, particularly in the development of foundation models (FMs) and consumer chatbots.

It said in its decision that while the acquisition qualified as a merger under UK law, it did not raise substantial competition concerns.

Inflection AI, a developer of the chatbot Pi, had a small market presence, and its products were not seen as material competitors to Microsoft's chatbot offerings, such as Copilot and ChatGPT.

The CMA found that Inflection's technology, while focused on emotional intelligence, did not significantly constrain Microsoft's dominance or other competitors in the field.

It also concluded that the acquisition would not harm competition in the enterprise-focused FM sector.

Inflection's AI studio business, which had been in the early stages of development, was not seen as a competitive threat to Microsoft or other established FM developers.

As a result, the CMA decided not to refer the merger for further investigation, clearing the way for the transaction to proceed.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

PepsiCo cuts revenue outlook again
(Sharecast News) - PepsiCo cut its annual organic revenue guidance again on Tuesday as it highlighted a "subdued" performance in North America in the third quarter.
Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.